![]() This includes a higher risk of SARS-CoV-2 infection, severe disease, hospitalisation, ICU admission and death as well as associated costs. IC populations remain at higher risk of severe COVID-19 outcomes than people with healthy immune systems. With the rapid evolution of Omicron variants that reduced or removed authorised therapies for COVID-19 prevention, many IC individuals are now left without active or passive protection while potential new therapies are being studied. In fact, more than one in 10 IC patients do not develop the antibodies needed for protection even after five or more COVID-19 vaccinations. 8 Thus, people with compromised immune systems such as people with cancer, organ transplant recipients or people taking immunosuppressive medicines may not be well protected against COVID-19, even when vaccinated. Vaccines require a healthy immune system and help jumpstart the body’s natural ability to produce infection-fighting cells. Protection is essential for the IC who shoulder disproportionate health and financial burdens from COVID-19 COVID-19 deaths were about seven times higher in 2022 compared to the 2022-2023 influenza season 5,6.Peak COVID-19 hospitalisation rates during winter 2022-2023 were 1.24 times higher and 2.08 times higher than peak influenza and RSV hospitalisation rates, respectively 5-7.1 Yet, COVID-19 presents a greater threat of disruption to public health than other prevalent respiratory diseases such as influenza or RSV and continues to impact patients and healthcare systems worldwide: In May 2023, the World Health Organization declared COVID-19 no longer constitutes a public health emergency. 4 COVID-19 continues to cause widespread disruption around the world 2,3 This can leave them feeling frustrated, isolated and unprotected. 1 Many who are immunocompromised cannot mount an adequate response to COVID-19 vaccination, and therefore remain at higher risk for severe COVID-19, hospitalisation and death than the general population. However, the burden on immunocompromised (IC) individuals is still significant and likely to remain heading into 2023-2024 winter season. Government and healthcare organisations have reduced their sense of urgency, and much of the general public has started to fully embrace a return to pre-pandemic life. Government and healthcare organisations have reduced their sense of urgency, and much of the general public has started to fully embrace a return to pre-pandemic life.Īttention is being re-directed from protecting against the disease to other areas such as economic recovery. Attention is being re-directed from protecting against the disease to other areas such as economic recovery. ![]() ![]() Partnerships, alliances and recognitionĪfter more than three years, much of the world has moved on from COVID-19.Mayor Bowser Twitter: Bowser Instagram: Bowser Facebook: facebook. Proactively receiving your recommended boosters and vaccinations can dramatically reduce respiratory illness across the District and protect the health of our families, friends, and communities. The flu vaccine is for individuals 6 months or older. Flu Vaccine: The annual flu vaccine is now widely available through healthcare providers and pharmacies.DC Health is currently working to allow the RSV vaccine to be available at pharmacies without a prescription.Ī monoclonal RSV preventative treatment is also available for certain high risk children 24 months and younger families and caregivers should consult with their child’s health care provider. A new RSV vaccine has been approved for individuals 60 or older and is now available through healthcare providers and, for people who have a prescription, at pharmacies. RSV Vaccine: According to the CDC, every year, respiratory syncytial virus (RSV) leads to approximately 60,000-120,000 hospitalizations and 6,000-10,000 deaths in the U.S.Find sites with the updated COVID-19 booster at. The new booster has been shown to be effective against many of the currently circulating variants by providing significant protections against severe COVID-19 hospitalization. These boosters will become widely available through healthcare providers and pharmacies within the next two weeks. Updated COVID-19 Booster: This week, the Centers for Disease Control and Prevention (CDC) approved a new COVID-19 booster for everyone 6 months or older.(Washington, DC) – Today, Mayor Muriel Bowser and DC Health are encouraging District residents to protect themselves, their families, and the community from respiratory illnesses by receiving new and existing vaccines and boosters for COVID-19, RSV, and the flu.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |